![A 42 kDa protein co-precipitates with ALCAM from KG1a cells, as indicated by the arrows. KG1a and undifferentiated Mutz-3 control cells (no ALCAM expression) were incubated overnight with [35S]methionine/cysteine. ALCAM was immunoprecipitated from labeled cell lysates with 1 g of AZNL51. Samples that were incubated with protein G beads alone (–) are shown as negative controls.](https://res.cloudinary.com/ximbio/image/upload/c_fit,fl_lossy,q_auto/610e33c5-152d-410a-95c4-0bf5db4db80a.png)
![A 42 kDa protein co-precipitates with ALCAM from KG1a cells, as indicated by the arrows. KG1a and undifferentiated Mutz-3 control cells (no ALCAM expression) were incubated overnight with [35S]methionine/cysteine. ALCAM was immunoprecipitated from labeled cell lysates with 1 g of AZNL51. Samples that were incubated with protein G beads alone (–) are shown as negative controls.](https://res.cloudinary.com/ximbio/image/upload/c_limit,fl_lossy,h_282,q_auto,w_368/610e33c5-152d-410a-95c4-0bf5db4db80a.png)
![Image thumbnail for Anti-ALCAM AZN-L51 (IgG1) [AZNL51] monoclonal antibody](https://res.cloudinary.com/ximbio/image/upload/c_fit,fl_lossy,h_45,q_auto/610e33c5-152d-410a-95c4-0bf5db4db80a.png)
Anti-ALCAM AZN-L50 (IgG2A) [AZNL50] monoclonal antibody
Invented by Carl G. Figdor at Radboud UMC
FACS
IP
WB
Antigen/Gene or Protein Targets: Activated leukocyte cell adhesion molecule
0
reviews
1
reference
1
supplier
